dipyridamole has been researched along with Elevated Cholesterol in 17 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole anti-platelet therapy has previously been suggested to ameliorate chronic tissue ischemia in healthy animals." | 7.77 | Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress. ( Bir, SC; Branch, BG; Greber, E; Kevil, CG; Pardue, S; Patel, RP; Pattillo, CB; Shen, X, 2011) |
| "Dipyridamole anti-platelet therapy has previously been suggested to ameliorate chronic tissue ischemia in healthy animals." | 3.77 | Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress. ( Bir, SC; Branch, BG; Greber, E; Kevil, CG; Pardue, S; Patel, RP; Pattillo, CB; Shen, X, 2011) |
| "An all the patients with left ventricular hypertrophy (LVH) had decreased CFVR whose values with the myocardial mass index above 130 g/m2 were significantly less than those in the absence of LVH." | 1.32 | [Coronary flow vasodilator reserve in patients with type 2 diabetes mellitus-associated arterial hypertension]. ( Efimova, EV; Karpov, RS; Koshel'skaia, OA; Ocheredko, NA; Panafidin, AV; Soldatenko, MV, 2004) |
| "Hypertriglyceridemia is an independent factor for this abnormality." | 1.30 | Altered myocardial vasodilatation in patients with hypertriglyceridemia in anatomically normal coronary arteries. ( Aoyagi, T; Kobayakawa, N; Momomura, S; Ohtake, T; Omata, M; Sasaki, Y; Sugiura, S; Yokoyama, I; Yonekura, K, 1998) |
| "When dipyridamole was administered in chickens fed the same diet without cholesterol no significant changes were observed." | 1.28 | Antihypercholesterolemic effect of dipyridamole in chickens. ( Arenas, C; Sánchez-Medina, F; Sánchez-Pozo, A, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (29.41) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gimelli, A | 1 |
| Marzullo, P | 1 |
| L'Abbate, A | 1 |
| Rovai, D | 1 |
| Pattillo, CB | 1 |
| Bir, SC | 1 |
| Branch, BG | 1 |
| Greber, E | 1 |
| Shen, X | 1 |
| Pardue, S | 1 |
| Patel, RP | 1 |
| Kevil, CG | 1 |
| García-Fuentes, E | 2 |
| Gil-Villarino, A | 2 |
| Zafra, MF | 2 |
| García-Peregrín, E | 2 |
| Nemes, A | 1 |
| Neu, K | 1 |
| Forster, T | 1 |
| Gruber, N | 1 |
| Csanády, M | 1 |
| Karpov, RS | 1 |
| Koshel'skaia, OA | 1 |
| Soldatenko, MV | 1 |
| Efimova, EV | 1 |
| Ocheredko, NA | 1 |
| Panafidin, AV | 1 |
| Zhong, ZM | 1 |
| Yu, L | 1 |
| Weng, ZY | 1 |
| Hao, ZH | 1 |
| Zhang, L | 1 |
| Zhang, YX | 1 |
| Dong, WQ | 1 |
| Stamler, J | 1 |
| Yokoyama, I | 3 |
| Ohtake, T | 3 |
| Momomura, S | 3 |
| Nishikawa, J | 1 |
| Sasaki, Y | 3 |
| Omata, M | 3 |
| Yonekura, K | 2 |
| Kobayakawa, N | 2 |
| Aoyagi, T | 2 |
| Sugiura, S | 2 |
| Baller, D | 1 |
| Gleichmann, U | 1 |
| Notohamiprodjo, G | 1 |
| Weise, R | 1 |
| Holzinger, J | 1 |
| Montanus, H | 1 |
| Betker, S | 1 |
| Lehmann, J | 1 |
| Yang, W | 1 |
| Yamada, N | 1 |
| Ohtomo, K | 1 |
| Yazaki, Y | 1 |
| Faergeman, O | 1 |
| Gormsen, J | 1 |
| Meinertz, H | 1 |
| Sánchez-Pozo, A | 1 |
| Arenas, C | 1 |
| Sánchez-Medina, F | 1 |
| Aviram, M | 1 |
| Winterstein, G | 1 |
| Brook, JG | 1 |
| Verbeuren, TJ | 1 |
| Coene, MC | 1 |
| Jordaens, FH | 1 |
| Van Hove, CE | 1 |
| Zonnekeyn, LL | 1 |
| Herman, AG | 1 |
| Velasco Martin, A | 1 |
| Perezagua Clamagirand, C | 1 |
2 trials available for dipyridamole and Elevated Cholesterol
| Article | Year |
|---|---|
[Therapeutic effect of Ginkgo biloba leaf extract on hypercholestrolemia in children with nephrotic syndrome].
Topics: Adolescent; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Female; Ginkgo biloba; | 2007 |
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; D | 1983 |
15 other studies available for dipyridamole and Elevated Cholesterol
| Article | Year |
|---|---|
'False-positive' myocardial perfusion imaging: correlation with cardiovascular risk factors and effect on event-free survival.
Topics: Aged; Angina Pectoris; Coronary Circulation; Diabetes Mellitus; Dipyridamole; Electrocardiography; E | 2008 |
Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress.
Topics: Animals; Diabetes Mellitus, Experimental; Dipyridamole; Disease Models, Animal; Hindlimb; Hyperchole | 2011 |
Changes in plasma lipid composition induced by coconut oil. Effects of dipyridamole.
Topics: Animals; Chickens; Coconut Oil; Dietary Fats; Dipyridamole; Hypercholesterolemia; Lipids; Male; Plan | 2002 |
Relationship between hypercholesterolemia, lipid-lowering therapy and coronary flow velocity reserve evaluated by stress transesophageal echocardiography in patients with a negative coronary angiogram.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Flow Velocity; Cholesterol; Coronary Angiography; Coron | 2004 |
[Coronary flow vasodilator reserve in patients with type 2 diabetes mellitus-associated arterial hypertension].
Topics: Coronary Artery Disease; Coronary Circulation; Diabetes Mellitus, Type 2; Dipyridamole; Echocardiogr | 2004 |
Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis.
Topics: Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cineangiography; Coronary Angiograp | 1996 |
Altered myocardial vasodilatation in patients with hypertriglyceridemia in anatomically normal coronary arteries.
Topics: Aged; Coronary Circulation; Coronary Vessels; Dipyridamole; Electrocardiography; Female; Hemodynamic | 1998 |
[Improved coronary vasodilator capacity by drug lipid lowering therapy in patients in the early stage of coronary atherosclerosis with reduced coronary reserves and moderate LDL hypercholesteremia].
Topics: Adult; Aged; Cholesterol, LDL; Combined Modality Therapy; Coronary Angiography; Coronary Artery Dise | 1998 |
Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy.
Topics: Aged; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Diabetes Mellitus; Dipyridamo | 1999 |
Dipyridamole prevents the coconut oil-induced hypercholesterolemia. A study on lipid plasma and lipoprotein composition.
Topics: Animals; Chickens; Coconut Oil; Dietary Fats; Dipyridamole; Food Deprivation; Hypercholesterolemia; | 2002 |
Anti-platelet drugs and portacaval anastomosis for homozygous hypercholesterolaemia.
Topics: Adolescent; Adult; Aspirin; Child; Dipyridamole; Female; Homozygote; Humans; Hypercholesterolemia; M | 1976 |
Antihypercholesterolemic effect of dipyridamole in chickens.
Topics: Animals; Chickens; Cholesterol; Cholesterol, Dietary; Dipyridamole; Hypercholesterolemia; Lipoprotei | 1992 |
Differential effect of platelet inhibitors in normal and in hypercholesterolaemic subjects.
Topics: Adult; Aspirin; Cyclic AMP; Dipyridamole; Epoprostenol; Humans; Hypercholesterolemia; In Vitro Techn | 1985 |
Effect of hypercholesterolemia on vascular reactivity in the rabbit. II. Influence of treatment with dipyridamole on endothelium-dependent and endothelium-independent responses in isolated aortas of control and hypercholesterolemic rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, Dietary; Dipyridamole; Hype | 1986 |
[Dipyridamole and lipid metabolism].
Topics: Administration, Oral; Adult; Aged; Dipyridamole; Female; Humans; Hypercholesterolemia; Male; Middle | 1969 |